Narender86

Nouvel article créé

2 années depuis - Traduire

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis | #rootsanalysis #pharma #health

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity

Nouvel article créé

2 années depuis - Traduire

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots Analysis | #rootsanalysis #pharma #health

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030, predicts Roots A

A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers

Nouvel article créé

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth around USD 14 Billion in 2030, claims Roots Analysis | #rootsanalysis #pharma #health

The CAR-T therapies market is characterized by a healthy pipeline of promising therapies, and is projected to be worth a

Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antige

Nouvel article créé

2 années depuis - Traduire

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030, predicts Roots Analysis | #rootsanalysis #pharma #health

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million in 2030, predicts Ro

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of diagnostic development services over the next decade. It features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. I

Nouvel article créé

2 années depuis - Traduire

The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis | #rootsanalysis #pharma #health

The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claim

Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list

Détails
14 des postes
Mâle